Insider · CIK 0001567077

Vaughn Victor

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001567077

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-04-19	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+7,850 sh	$25.30	+$199K	17,194
2018-04-19	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of Sales & Marketing	SSale	−7,850 sh	$49.03	−$385K	9,344
2018-04-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−7,850 sh	—	—	38,400
2018-04-18	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+6,250 sh	$12.98	+$81.1K	15,594
2018-04-18	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+3,750 sh	$25.30	+$94.9K	19,344
2018-04-18	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of Sales & Marketing	SSale	−10K sh	$47.06	−$471K	9,344
2018-04-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−6,250 sh	—	—	25,000
2018-04-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−3,750 sh	—	—	46,250
2018-04-05	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+15K sh	$9.24	+$139K	24,344
2018-04-05	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of Sales & Marketing	SSale	−15K sh	$45.33	−$680K	9,344
2018-04-05	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+26.3K sh	$9.13	+$240K	35,594
2018-04-05	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of Sales & Marketing	SSale	−26.3K sh	$45.33	−$1.19M	9,344
2018-04-05	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+18.8K sh	$12.98	+$243K	28,094
2018-04-05	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of Sales & Marketing	SSale	−18.8K sh	$45.33	−$850K	9,344
2018-04-05	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−15K sh	—	—	0
2018-04-05	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−26.3K sh	—	—	8,750
2018-04-05	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−18.8K sh	—	—	31,250
2018-02-14	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP of Sales & Marketing	AAward	+33K sh	—	—	33,000
2018-01-17	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+9,250 sh	$7.90	+$73.1K	18,594
2018-01-17	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of Sales & Marketing	SSale	−9,250 sh	$45.00	−$416K	9,344
2018-01-17	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+15K sh	$9.24	+$139K	24,344
2018-01-17	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of Sales & Marketing	SSale	−15K sh	$47.03	−$705K	9,344
2018-01-17	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−9,250 sh	—	—	0
2018-01-17	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−15K sh	—	—	15,000
2018-01-12	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+5,750 sh	$7.90	+$45.4K	15,094
2018-01-12	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of Sales & Marketing	SSale	−5,750 sh	$45.03	−$259K	9,344
2018-01-12	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−5,750 sh	—	—	9,250
2018-01-02	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	+55K sh	$7.90	+$435K	64,344
2018-01-02	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of Sales & Marketing	SSale	−55K sh	$40.11	−$2.21M	9,344
2018-01-02	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of Sales & Marketing	MExercise/Conversion	−55K sh	—	—	30,000
2017-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP of Sales & Marketing	AAward	+50K sh	—	—	50,000
2016-03-01	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP of Sales & Marketing	AAward	+50K sh	—	—	50,000
2015-03-03	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP of Sales & Marketing	AAward	+35K sh	—	—	35,000
2014-01-21	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP of Sales & Marketing	AAward	+30K sh	—	—	30,000
2013-02-05	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP of Sales & Marketing	AAward	+85K sh	—	—	85,000

Recent filings

Accepted (ET)
Apr 204
Vaughn Victor0001104659-18-025639
SEC(opens sec.gov)
Apr 94
Vaughn Victor0001104659-18-023012
SEC(opens sec.gov)
Feb 164
Vaughn Victor0001104659-18-010412
SEC(opens sec.gov)
Jan 174
Vaughn Victor0001104659-18-002701
SEC(opens sec.gov)

Companies

SUPERNUS PHARMACEUTICALS, INC.Sr. VP of Sales & MarketingSUPN

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE

ROCKVILLE, MD, 20850